logo
Plus   Neg
Share
Email

Roche Unveils New Quantitative Antibody Test To Measure SARS-CoV-2 Antibodies

Swiss drug maker Roche Group (RHHBY) announced Friday the launch of its Elecsys Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark.

The company has filed for Emergency Use Authorisation or EUA from the U.S. Food and Drug Administration. The new test is expected to support the evaluation of vaccines.

The new Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 or SARS-CoV-2. The test targets antibodies against the spike protein. This is the focus of vaccines in development and convalescent plasma therapy.

The new test is the twelfth in the Roche SARS-CoV-2 testing portfolio.

Roche noted that the new Elecsys Anti-SARS-COV-2 S antibody test, together with the Elecsys Anti-SARS-CoV-2 test launched in May, can help to more effectively determine the percentage of a population who already have antibodies against SARS-COV-2.

Thomas Schinecker, CEO Roche Diagnostics, said, "As the possibility of an effective SARS-CoV-2 vaccine becomes a reality, quantitative measurement of antibodies will be crucial in the evaluation of any potential vaccine. The new quantitative Elecsys antibody test can play a pivotal role in vaccine clinical trials as well as helping clinicians assess patients immune response."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT